Switching HIV-infected, suppressed patients from ABC/3TC to FTC/TDF improves lipids - the SETTLE study

被引：0
|
作者：
Gathe, J. C., Jr. [1 ]
机构：
[1] Therapeut Concepts, Houston, TX USA
来源：
ANTIVIRAL THERAPY | 2008年 / 13卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：A61 / A62
页数：2
相关论文
共 50 条
  • [21] Improvement in lipid profile in HIV-infected virologically controlled patients switched to a simple QD regimen:: results of the COOL trial evaluating EFV/TDF versus EFV/TDF/3TC
    Mercie, P.
    Trylesinski, A.
    Cabie, A.
    Michelet, C.
    Verdon, R.
    Katlama, C.
    Weiss, L.
    Caubet, O.
    Sereni, D.
    Bentata, M.
    Durant, J.
    Simon, A.
    Morand-Joubert, L.
    Chene, G.
    Petour, P.
    Girard, P. M.
    ANTIVIRAL THERAPY, 2006, 11 (07) : L48 - L49
  • [22] Cost-effectiveness of DTG+ABC/3TC versus EFV/TDF/FTC for first-line treatment of HIV-1 in the United States
    Peng, Siyang
    Tafazzoli, Ali
    Dorman, Emily
    Rosenblatt, Lisa
    Villasis-Keever, Angelina
    Sorensen, Sonja
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17 : 78 - 78
  • [23] Effectiveness and tolerability of abacavir-lamivudine-nevirapine (ABC/3TC/NVP) in a multicenter cohort of HIV-infected ARV-experienced patients
    Podzamczer, D.
    Ferrer, E.
    Llibre, J.
    Leal, M.
    Crusells, M.
    Knobel, H.
    Curto, J.
    Puig, J.
    Gorgolas, M.
    Gomez-Sirvent, J.
    Domingo, P.
    Rozas, N.
    Lopez-Bernaldo de Quiros, J.
    Ocampo, A.
    Vergas, J.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15 : 159 - 160
  • [24] Effectiveness and tolerability of abacavir-lamivudine-nevirapine (ABC/3TC/NVP) in a multicentre cohort of HIV-infected, ARV-naive patients
    Podzamczer, Daniel
    Fredy Rojas, Jhon
    Neves, Isabel
    Ferrer, Elena
    Llibre, Josep M.
    Leal, Manuel
    Gorgolas, Miguel
    Jose Crusells, Ma
    Gatell, Josep Ma
    Correia Abreu, Ricardo
    Curto, Jordi
    Domingo, Pere
    Pilar Barrufet, Ma
    Rozas, Nerea
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17 : 172 - 172
  • [25] Improvement in lipid profile in HIV-infected virologically controlled patients switched to a simple QD regimen:: Preliminary results of the COOL trial evaluating EFV/TDF vs EFV/TDF/3TC
    Mercié, P
    Trylesinski, A
    Cabié, A
    Michelet, C
    Verdon, R
    Katlama, C
    Weiss, L
    Pellegrin, JL
    Sereni, D
    Bentata, M
    Durant, J
    Simon, A
    Morand-Joubert, L
    Chêne, G
    Girard, PM
    ANTIVIRAL THERAPY, 2004, 9 (06) : L48 - L48
  • [26] PHARMACOKINETICS OF 3TC (GR109714X) ADMINISTERED WITH AND WITHOUT FOOD TO HIV-INFECTED PATIENTS
    ANGEL, JB
    HUSSEY, EK
    HALL, ST
    DONN, KH
    MORRIS, DM
    MCCORMACK, JP
    MONTANER, JSG
    RUEDY, J
    DRUG INVESTIGATION, 1993, 6 (02): : 70 - 74
  • [27] Bone mineral density, kidney function, weight gain and insulin resistance in women who switch from TDF/FTC/NNRTI to ABC/3TC/DTG
    Ibrahim, F.
    Samarawickrama, A.
    Hamzah, L.
    Vincent, R.
    Gilleece, Y.
    Waters, L.
    Kegg, S.
    Barbini, B.
    Campbell, L.
    Post, F. A.
    HIV MEDICINE, 2021, 22 (02) : 83 - 91
  • [28] A pilot trial on initial treatment of HIV-infected pregnant women with 3TC/DTG: The PREGNANT Study
    Brites, C.
    Luz, E.
    Nobrega, I.
    Luz, I.
    Zajdenverg, R.
    De Ruiter, A.
    Lorenzo, C.
    Travassos, A. G.
    HIV MEDICINE, 2023, 24 : 513 - 514
  • [29] Limb fat changes 48 weeks after switching from AZT/3TC to FTC/TDF versus continuing on AZT/3TC. Primary endpoint analysis of the RECOMB trial
    Martinez, E.
    Ribera, E.
    Clotet, B.
    Estrada, V.
    Sanz, J.
    Berenguer, J.
    Rubio, R.
    Pulido, F.
    Larrouse, M.
    Curran, A.
    Negredo, E.
    Arterburn, S.
    Ferrer, P.
    Alvarez, M. L.
    ANTIVIRAL THERAPY, 2008, 13 (08) : A47 - A48
  • [30] Efficacy and safety of switching to dolutegravir plus emtricitabine/tenofovir disoproxil fumarate (TDF) or elvitegravir/cobicistat/emtricitabine/TDF in virologically suppressed HIV-infected patients in clinical practice: results from a multicentre, observational study
    Baldin, G.
    Ciccullo, A.
    Capetti, A.
    Rusconi, S.
    Sterrantino, G.
    Cossu, M. V.
    Giacomelli, A.
    Lagi, F.
    Latini, A.
    Bagella, P.
    De Luca, A.
    Di Giambenedetto, S.
    Madeddu, G.
    HIV MEDICINE, 2019, 20 (02) : 164 - 168
12345